Timely recognition of the signs and symptoms of posterior circulation stroke (PCS) is critical for properly diagnosing PCS, understanding the clinical course, and managing patients with acute PCS diagnosis. Delayed or incorrect diagnosis results in inadequate acute care and poorer outcomes. While PCS can be challenging to recognize; in this webinar series learn to distinguish characteristic clinical patterns and apply AHA/ACC guideline recommendations.
Webinars
Videos On Demand
Intracerebral hemorrhages (ICHs) are the deadliest form of acute stroke. International leaders in ICHs address recent advances in the diagnosis, treatment, and prevention of ICH, as well as acute care, intervention, and complications.
CE Credits Available.
Hypertension increases with age and treatment-resistant hypertension exists within the US population. Participants in this activity will learn about treatment options for patients with resistant hypertension, how to address healthcare disparities in treatment and management, and shared decision-making strategies to improve health equity.
CE and MOC Credits Available.
This case-based presentation is designed to provide learners with the evidence and knowledge they require to incorporate guideline-based care and new research findings into their management of patients with AF, including the appropriate use of rate and rhythm control options, anticoagulants, anti-arhythmic drugs, lifestyle approaches, and non-pharmacologic therapies, as well as understand ethnic/racial differences in outcomes for AF.
CE and MOC Credits Available.
Improved awareness of Peripheral Artery Disease (PAD) symptoms, risk factors and complications are imperative to avoid missed diagnosis and underused treatment for PAD. Join this live webinar and learn the important racial, gender, socioeconomic, and geographical disparities in PAD. Help your patients understand the risk factors, signs and symptoms and treatments for PAD.
Participation in activities of daily life can be challenging for those with transthyretin amyloid cardiomyopathy (ATTR-CM), a restrictive cardiomyopathy produced by extracellular deposition of transthyretin. Geographic and racial healthcare disparities add to the burden of disease. Shared decision making and early detection with readily available noninvasive tests, among other strategies, are essential as therapy for ATTR-CM.
CE and MOC Credits Available. Approved for 1.0 AAFP Prescribed Credit.
Futuristic digital drawing of a transparent human head, showing location of some blood vessels and brain. This online course provides the most current and comprehensive scope of knowledge in the early assessment and management of vascular cognitive impairment. The presentations from experts in the field will challenge and expand on contemporary patient care across the age continuum.
Patient Care Post-Acute Myocardial Infarction: The First 90 Days
What variables predict readmission within 90 days of hospitalization for myocardial infarction? Does structural racism contribute to the inequities in healthcare delivery? Watch these webinars and learn:
Surgical and interventional options such as surgical myectomy or alcohol septal ablation may help those with obstructive HCM to reduce or remove the obstruction. A similar option is unavailable to those with non-obstructive HCM. Heart transplants are considered as a last resort for HCM patients who progress to end stages of the disease. Learn the latest in the clinical management of HCM in this free webinar.
Presenters: Anjali Tiku Owens, MD; Richard Bach, MD, FAHA, FACC, FSCAI
Moderator: James E. Udelson, MD, FAHA
Bristol Myers Squibb is a national sponsor of the American Heart Association’s hypertrophic cardiomyopathy initiative.
While a precise percentage of cryptogenic strokes is unknown, approximately 35% of strokes are thought to be cryptogenic. This suggests nearly 240,000 strokes annually for which no clear etiology can be distinguished. Experts concur the embolic insult in cryptogenic stroke may be due to subclinical atrial fibrillation (AF). It is estimated about 15% of ischemic strokes are caused by AF and that there is an elevated risk of secondary ischemic stroke due to AF.
This 3-part educational webinar series on cryptogenic stroke focuses on the 2021 Guideline for the Prevention of Stroke in Patients with Stroke and Transient Ischemic Attack.
CE credit available
Supported by an Education Grant by Medtronic
Presenters: Cheryl Dennison Himmelfarb, PhD, RN, ANP, FAHA; Giv Heidari-Bateni, MD
Moderator: Eunjoo An, PhD, RN
Shared decision-making has become a method to enhance patient involvement in health care decisions, patient-provider communication, and patient-centered care. When selecting the best hypertension management plan, your patients may have different goals and preferences for treatment. Adherence may be increased if the plan aligns with the patient’s preferences. In this webinar you will learn how to engage your patients and incorporate shared decision making into your practice. Barriers to implementing strategies will also be discussed.
Supported by an education grant from Medtronic.
Empowering Your Patients to Understand ATTR-CM
In this first of a 3-part series, watch Nancy M. Albert and Katherine E. Di Palo join moderator Kevin Alexander in discussing ways to empower patients to recognize ATTR-CM and share in decision-making about diagnostic and treatment options. CE/ABIM MOC credit available. Approved for 1.0 AAFP Prescribed/Elective credits. Free webinar.
Guidelines and Statements
Access the knowledge you need right in your browser. Learn from experts who share practical applications and considerations in the latest statements and guidelines. Improved patient care starts with you. Start learning today.
Secondary Stroke Prevention: Evidence-based Recommendations
This webinar is highlights evidence-based clinical recommendations from the recently published 2021 Guideline for the Prevention of Stroke in Patients with Stroke and Transient Ischemic Attack. Patients having had an ischemic stroke/transient ischemic attack may experience improved outcomes and quality of life based on the prevention strategies for reducing subsequent stroke risk.
Ethics and Professionalism: A Common Ground of Understanding
A roundtable discussion on issues like shared clinical decision-making; the relationship of clinicians with patients, other clinicians, and organizations; allocation of resources; and scientific responsibility and integrity in research.
Key Implications for Clinicians in the 2020 AHA/ACC Guideline for the Management of Patients with Valvular Heart Disease
In your evaluation of patients with suspected valvular heart disease, learn the diagnostic strategies for early detection of valvular disease and long term management with appropriate tools for assessment and intervention.
Posterior Circulation Stroke Webinar Series
Hidden in Plain Sight – What Do You Know About ATTR Amyloidosis?
Start with these two questions!
{{ formCtrl.response.ResponseTitle }}
{{ formCtrl.response.ResponseTitle }}
EmailResults
How did you do?
Your score: {{ formCtrl.response.Summary.TotalScore }}
Your Summary
-
Question{{item.Question}}Your Answers•{{answer}}{{item.Tip}}
|
|
Your Summary
|
|
{{++index}}. {{item.Question}}
|
Join a Webinar Series – Available On-Demand
With your help, patients whose lives have been restricted due to HCM may be able to reduce symptoms and comorbidities. Register today and increase your knowledge of the latest HCM science.
Amyloidoses are a heterogeneous group of systemic disorders characterized by extra cellular deposition of a protein-derived material (known as amyloid) that disrupts normal tissue structure and function. Improve the care of patients with Transthyretin Amyloidosis (ATTR amyloidosis) by closing practice and knowledge gaps in disease presentation as experts discuss the complexities of this progressive, degenerative, and multisystemic disorder.
Address gaps in your knowledge about Lipoprotein(a) and LDL-C. Watch these evidence-based webinars recognizing the latest science and gain expert insights into incorporating the measurement of Lp(a) into patient evaluation and risk assessment. CE/MOC available.
Webinar series supported by an education grant from Kaneka Corporation.